Staburo @ DAGStat 2022 in Hamburg

Apr 11, 2022
Hamburg

Staburo statisticians joined the DAGStat conference 2022 in Hamburg, March 28 to April 1, hosted at the University Medical Center Hamburg-Eppendorf. One goal of the joint statistical meeting of the German Consortium for Statistics (Deutsche Arbeitsgemeinschaft Statistik, DAGStat) is to stimulate constructive discussions between the representatives of the various statistical areas summarized by the DAGStat theme >>Statistics under one umbrella<< (an umbrella being a conference present in Hamburg 😉). This year, the central DAGStat theme was complemented by the motto >>Mind the gap – Interplay between theory and practice<<. In this sense the Staburo statisticians updated themselves about current research topics which could be applied to biostatistical questions in their daily work. Research areas of interest included: Design of experiments and clinical trials, clustering and classification, statistics in the pharmaceutical and medical device industry, survival and event history analysis, the STRATOS (STRengthening Analytical Thinking for Observational Studies) initiative, causal inference, robustness of statistical conclusions, and cross-validation. As a lesson learned from SARS-CoV-2 pandemic and climate change, with extreme weather events, the role and importance of statistics and data science to science and society, and the need to prepare for future challenges was intensely discussed.

More Articles

7th Staburo Health Data Science Summit 

7th Staburo Health Data Science Summit 

The 7th Staburo Health Data Science Summit brought together experts from the pharmaceutical and life sciences industries to explore the evolving role of biomarkers and data science in advancing precision medicine.  With contributions from leading organizations,...

read more
Staburo @ ISCB/GMDS Conference 2026

Staburo @ ISCB/GMDS Conference 2026

Staburo Team Selected to Present at ISCB/GMDS Conference 2026 We are pleased to share that Maria Stark, Senior Data Scientist, and the team representing Staburo in the GMDS Biostatistics Competition have been selected to present their work at the upcoming ISCB/GMDS...

read more
Biomarkers at Staburo

Biomarkers at Staburo

In 2024 at Staburo was about building momentum in the area Biomarkers. Deepening our engagement in the PSI Biomarker SIG, strengthening collaborations, and developing the ideas that would later become deliverables. In 2025, we developed and released ShadowVIMP, an R...

read more